Skip to main content
KREDKRED
008930KOSPI

Hanmi Science

54,900
-3,200 (-5.51%)

Price chart

  • MA5
  • MA20
  • MA60

Adjusted prices rescale past bars with coefficients taken from the base prices the exchange itself published, correcting for corporate actions such as stock splits and reverse splits. Cash dividends are not reflected, and the risk measures on this page never use these adjusted figures.

Market capitalizationKRW 1T

Each day's close multiplied by the listed share count of this share class alone, sampled weekly. It is the figure for this issue only, not a combined total across common and preferred shares.

Overview

Summary

Hanmi Science is a holding company established in 1973. It is listed on the KOSPI market and is headquartered in Hwaseong, Gyeonggi Province.

The company operates as an operational holding company. Its business segments include holding, healthcare, pharmaceutical wholesale, and others. It provides medical devices, consumer health products, and IT solutions, and distributes pharmaceuticals and health functional foods through a B2B e-commerce platform and sales networks.

Business overview as filed

한미사이언스(주)는 사업형 지주회사로서 자회사의 지분이익, 특허권 및 상표권 사용료 수입, 헬스케어 사업, 계열사 관리 등을 통해 자체적으로 수익을 창출하고 있으며,이를 기반으로 신성장동력 발굴, 신약개발의 리스크 분담, 중장기 성장 전략 수립 및 신사업 투자 등에 매진하고 있습니다.

연결회사의 영업부문은 지주부문, 헬스케어사업부문, 의약품도매부문, 기타부문으로 구성됩니다.

1) 지주부문

자회사의 지분이익, 특허권 및 상표권 사용료 수입, 계열사 관리 등을 통해 자체적으로 수익을 창출하고 있으며, 이를 기반으로 신성장동력 발굴, 신약개발의 리스크 분담, 중장기 비전 수립 등에 매진하고 있습니다.

2) 헬스케어사업부문

의료기기본부, 컨슈머헬스본부, IT솔루션사업본부로 나뉘어 의료기기 사업, 식품 제조 및 유통 사업, 뷰티케어 사업, 제약 특화 IT솔루션 사업 등의 분야에서 지속적인 혁신제품 개발 및 시장개척에 앞장서고 있습니다.

3) 의약품 도매부문

약국과 병원 중심의 B2B전자상거래 플랫폼(HMP몰)과 전국 영업망을 통해 의약품 및 의약외품, 건강기능식품, 자동조제기(JVM), 음료, 화장품 등을 전문 유통하고 있으며, 온오프라인 통합 비즈니스 모델을 구축하여 약국 운영에 필요한 모든 물품을 유통하는 약국 경영 파트너로 자리매김하고 있습니다.

Company overview

1. 연결대상 종속회사 개황1) 연결대상 종속회사 현황(요약)

1-1) 연결대상회사의 변동내용

2) 회사의 법적, 상업적 명칭

당사의 명칭은 한미사이언스 주식회사이며, 영문으로는 Hanmi Science Co., Ltd.로 표기합니다.

3) 설립일자

당사의 설립일자는 1973년 6월 15일입니다.

4) 본사의 주소 및 홈페이지 주소

본사의 주소: 경기도 화성시 만세구 팔탄면 무하로 214홈페이지 주소: http://www.hanmiscience.co.kr

5) 중소기업 등 해당 여부

6) 주요 사업의 내용

한미사이언스(주)는 독점규제 및 공정거래에 관한 법률에 따라 2011년 4월 공정거래위원회에 지주회사 승인을 요청, 2011년 5월 지주회사로의 전환을 승인받았으며, 국내 회사의 사업 내용을 지배하는 것을 주된 사업으로 하는 회사입니다.아울러 당사는 2022년 11월 한미헬스케어(주)와의 합병을 통하여 의료기기, 컨슈머헬스, IT본부로 나뉘는 헬스케어사업부문을 사업부문에 추가하여 새로운 가치 창출을 하는 사업지주회사로서의 역할을 수행하고 있습니다.

7) 신용평가에 관한 사항

보고서 제출일 현재 당사의 기업신용등급 및 기업어음의 등급 현황은 아래와 같습니다.

8) 회사의 주권상장(또는 등록ㆍ지정) 및 특례상장에 관한 사항

Transcribed verbatim from the sentences the filer wrote in the fiscal 2025 business report (received 2026.03.20), tables and figures omitted.

  • The summary is written separately from the filed text and is not the filer's wording, so it may phrase things differently from or omit parts of the original, which is shown alongside for checking.
  • The company introduction reproduces the sentences the filer wrote in its business report, with tables, figures and the sentences that point to other sections of the report omitted, and the accuracy of their content has not been separately verified.

VaR

7.83%
[4.55%, 13.18%] · As of 2026-10-02
VaR by window

The headline's measure for each of the three windows on one scale, the dot being the estimate and the bar its interval. The windows are nested and share their observations, so the three readings are not three independent measurements. The selected window is highlighted.

Daily return distribution

The issue's daily returns over the chosen window counted into equal-width bins. The vertical lines mark the VaR and cVaR above on the loss side. The published VaR sample applies exclusion rules for halts and first sessions that this raw daily series does not, so the bars and the marks can differ slightly at the edges.

Drawdown

Deepest drawdown 48.5% (2026-06-26). How far below its previous peak the issue stood each day over the chosen window, a description of the path already travelled.

If these numbers are unfamiliarThere is a guide that walks through VaR, cVaR and annualized volatility in plain language.Read the guide

Characteristic line

0.24
Beta [0.04, 0.44] · KOSPI200 · As of 2026-10-08
Intercept
+0.094%[-0.360%, +0.549%]
R squared
0.05
Observations
252
Trading-time corrected beta
0.21[-0.07, 0.49]
252-day rolling beta

A 252-day window rolled one day at a time over the longest daily span of the characteristic line. It shows when the beta against the KOSPI200 and the annualized volatility of the issue's excess return rose and fell, and unlike the headline figures above it carries no interval.

252-day rolling annualized volatility

Each point is one period's index excess return and issue excess return, and the line is the regression fitted to those points. The risk-free rate is the certificate of deposit rate.

Financials

20152016201720182019202020212022202320242025TTM
RevenueKRW 100M7,7666,6536,5237,0808,1668,5749,50210,46112,47912,83413,57014,081
Revenue growth%—-14.34-1.958.5315.344.9910.8210.0919.302.855.73—
Operating incomeKRW 100M2,1642873912623803255896761,2459891,3871,697
Operating income growth%—-86.7636.37-33.0645.23-14.4481.0714.9184.05-20.5740.32—
Net incomeKRW 100M1,774793081803072264296901,1515671,1771,509
Net income growth%—-95.53288.12-41.5270.59-26.5090.0360.7766.76-50.75107.63—
Attributable to ownersKRW 100M——301180307——6921,1515941,1841,509
Attributable to minoritiesKRW 100M——700——-2-0-27-7-0
Operating margin%27.874.315.993.694.653.796.196.469.977.7010.2212.06
Net margin%22.851.194.722.553.762.644.526.609.234.428.6710.72
ROE%——4.522.764.76——9.5514.627.0712.3114.22
ROA%19.040.823.281.973.382.454.526.229.394.207.919.85
Debt ratio%59.5349.6841.1440.3441.0640.1537.6153.1155.7160.8555.2444.44
Current ratio%127.67108.30106.81107.5995.1398.01100.7170.5669.3169.9588.0590.38
Quick ratio%100.2176.9062.7862.3350.9247.9552.7638.2842.7746.7662.7159.81
Reserve ratio%———1,943.11—————2,296.462,658.712,847.47
OCF conversion%26.45963.73-109.2914.9942.3661.1531.8813.6930.54146.3840.49—
Receivable daysdays—100.865.753.943.038.135.033.830.530.128.0—
EPSKRW——4972904853436381,0101,6948781,7482,207
PERx——223.34272.4179.07221.8784.9532.1323.1433.5420.7413.66
BPSKRW—11,07010,68010,2859,9739,97910,25610,56111,25712,29614,06415,514
PBRx—5.5210.397.683.857.635.283.073.482.402.581.94
Dividend per shareKRW500—200200200200200200200300——
Payout ratio%——40.2468.9741.2458.3131.3519.8011.8134.17——

Consolidated basis

Margins%

Cash flow by activityKRW 100M

Balance sheet compositionKRW 100M

Debt ratio%

The left bar splits assets into current and non-current and the right bar splits the financing of those assets into liabilities and equity, so the two bars stand at the same height.

Quarterly resultsKRW 100M

Year-on-year growth%

Each quarterly bar is that quarter's three months and is never mixed with an annual figure. The growth rate is computed only where the same quarter a year earlier is also shown here, and is left blank when the base was a loss.

Cash conversion cycledays

Inventory days and receivable days stack upward, payable days hang downward, and the cash conversion cycle they net to is drawn as the line. Each day count uses the average balance with the prior year, so the oldest year is not drawn. A day count whose line was not filed is left out, and the cycle is shown only for years that carry all three.

Owners' net margin%

Asset turnoverx

Financial leveragex

ROE%

ROE is the product of the owners' net margin, asset turnover and financial leverage. All three use period-end balances as denominators, and profit and equity are on the owners' basis, so the product matches the ROE in the table.

Financial statements

Balance sheet

20152016201720182019202020212022202320242025
9,3209,6929,3889,1659,1089,2329,49911,09712,26213,49114,890
3,4783,2172,7362,6352,6512,6452,5963,8494,3875,1045,299
5,8426,4766,6526,5316,4576,5876,9037,2477,8758,3879,592

Income statement

20152016201720182019202020212022202320242025
7,7666,6536,5237,0808,1668,5749,50210,46112,47912,83413,570
2,1642873912623803255896761,2459891,387
2,3371893341883543004917321,3056311,330
1,774793081803072264296901,1515671,177
Basic earnings per shareKRWNot applicableNot applicable497290*485*343*638*1,0101,6948781,748
Diluted earnings per shareKRWNot applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicable8781,747
1,666927712157Not applicableNot applicable6728397291,324

Cash flow statement

20152016201720182019202020212022202320242025
Net incomefrom the income statement1,774793081803072264296901,1515671,177
Total adjustments to operating cash flowcomputed-1,305686-645-153-177-88-293-596-800263-701
469765-3372713013813795352830477
549-237-23039-325-68-22-21-187-69122
-300-449-61-18291-90-110-11-102-204-171
Cash at beginning of periodKRW 100M2209441,025384269167148166214276852
9441,0253842691671481662142768521,274
Net change in cash and cash equivalentsKRW 100M71880Not applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicableNot applicable

In the latest fiscal year operating and investing activities brought cash in while financing activities paid cash out.

A year whose own filing is absent is filled from the restated comparative in the following filing, and is marked as such. Operating indicators outside the statements, such as order backlogs, and audit opinions are not covered here, and per-share figures follow the filed values without retroactive adjustment for share splits.

Transcribed verbatim from the sentences the filer wrote in the fiscal {year} business report (received {date}), with tables, figures and cross-references to other sections omitted.

The newest annual filing shown was received on 2026.03.20.

Audit opinion

Fiscal yearOpinionAuditorFiscal year end
2025적정의견Term 53안진회계법인2025-12-31
2024적정의견Term 52안진회계법인2025-12-31
2023적정의견Term 51안진회계법인2025-12-31
2022적정Term 50한영회계법인2022-12-31
2021적정Term 49한영회계법인2022-12-31
2020적정Term 48한영회계법인2022-12-31
2019적정Term 47한영회계법인2019-12-31
2018적정Term 46삼일회계법인2019-12-31
2017적정Term 45삼일회계법인2019-12-31
2016적정Term 44삼일회계법인2016-12-31
2015적정Term 43안진회계법인2016-12-31
2014적정Term 42안진회계법인2016-12-31

The auditor's name and the opinion are transcribed verbatim from the filed audit report, and the wording follows the filer. A fiscal year shown twice means the filing carried two entries that the source does not distinguish.

Korean audit opinions come in four kinds, where an unqualified opinion (적정) finds the statements fairly presented, a qualified opinion (한정) does so except for a stated matter, an adverse opinion (부적정) finds them not fairly presented, and a disclaimer of opinion (의견거절) means the auditor could not obtain enough evidence to form a view.

Valuation

Valuation multiplesx

PER and PBR divide each period's closing price by the per-share figure filed for that same period, and a loss period is left blank. The quarterly view is a multiple of quarterly EPS.

Dividend historyKRW

The dividend-per-share bars are restated onto the current share basis for splits and par-value changes. The payout ratio and the dividend yield divide figures filed for the same period and are left unadjusted.

Payout ratio and dividend yield%

PER bandKRW

The price is the adjusted close and each band line multiplies the EPS of the latest completed fiscal year by a fixed multiple. The previous year's EPS stays in force until the next fiscal year ends, and the multiples divide the range between the lowest and highest annual PER on record into equal steps.

Valuation models

Five models priced under one set of assumptions, set beside the current price, with how each has moved by fiscal year.

Assumptions

Risk-free rate10-year treasury yield · 2026-10-084.40%
BetaDaily 5Y0.44
%
%
Cost of equity6.60%
Weighted average cost of capital—
Initial growth12.3%
Effective tax rate11.5%
Base fiscal year2025
Current priceKRW54,900

The risk premium and the terminal growth rate are adjustable assumptions, and the rest follow from the data and the formulas.

ModelModel priceKRWVersus current price
Gordon growth modelNo dividend
Dividend discount model DDMNo dividend
Discounted cash flow FCFFNo cash flow lines
Discounted cash flow FCFENo cash flow lines
Residual income model RIM38,778-29.4%
The table prices the newest fiscal year's accounts at today's treasury yield and the current price.

Dividend and residual income familyKRW

Discounted cash flow familyKRW

Each fiscal year's figures use that year's accounts and the treasury yield at its period end, with beta held at its current value, and splits or par changes are restated to the current share basis.

How the figures are calculated

Each model's formula is shown in symbols and then with this issue's own numbers substituted, step by step. Changing a value in the assumptions panel changes the numbers here too. Firm-level amounts are in hundred million won and per-share values in won.

Cost of equity

r=rf+β×ERPr = r_f + \beta \times \mathit{ERP}

r = 4.40% + 0.44 × 5.00% = 6.60%

Initial growth

g1=max⁡{ROE×(1−payout), 0},gt=g1+(gT−g1) t−1N−1g_1 = \max\{\mathit{ROE} \times (1 - \text{payout}),\,0\},\qquad g_t = g_1 + (g_T - g_1)\,\frac{t-1}{N-1}

g_1 = max(12.31% × (1 − 0.00%), 0) = 12.31%

Growth starts at this value in the first year and falls by equal steps each year to reach the terminal rate in the fifth

Residual income model RIM

P0=B0+∑t=1NRIt(1+r)t+RIN(1+gT)(r−gT) (1+r)N,RIt=(ROE−r) Bt−1P_0 = B_0 + \sum_{t=1}^{N} \frac{\mathit{RI}_t}{(1+r)^t} + \frac{\mathit{RI}_N (1+g_T)}{(r - g_T)\,(1+r)^N},\qquad \mathit{RI}_t = (\mathit{ROE} - r)\,B_{t-1}

B_0 = 14,064 KRW, ROE = 12.31%, payout ratio = 0.00%, r = 6.60%, g_T = 2.00%

YearOpening book valueEarningsEquity chargeResidual incomeDiscount factorPresent value
114,0641,7319298020.9380752
215,7951,9441,0439010.8799793
317,7382,1831,1711,0120.8254835
419,9212,4521,3161,1360.7743880
522,3732,7531,4781,2760.7263927
Terminal value28,2640.726320,529

P_0 = 14,064 + 4,186 + 20,529 = 38,778 KRW

The cost of equity is the risk-free rate plus beta times the equity risk premium. Initial growth is the newest fiscal year's return on equity times its retention ratio, floored at zero, and falls by equal steps from that value in the first year to the terminal rate in the fifth. Only the Gordon model grows at the terminal rate from the start. Discounted cash flow starts from operating cash flow less capital expenditure, where FCFF adds after-tax interest paid and discounts at the weighted average cost of capital, and FCFE adds net borrowing and discounts at the cost of equity. The residual income model adds to book value per share the present value of earnings above the equity charge.

Other issues on the same market

Neighbours in the market capitalisation order.

See the full KOSPI list